QTTB Q2 2020 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$567,000+44.6% YoY

Gross Profit

$00.0% margin

Operating Income

-$36M-6295.8% margin

Net Income

-$35M-6232.8% margin

EPS (Diluted)

$-14.07

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$258M

Total Liabilities

$64M

Stockholders' Equity

$195M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$567,000	$392,000	+44.6%
Gross Profit	$0	$0	—
Operating Income	-$36M	-$28M	-27.6%
Net Income	-$35M	-$26M	-34.5%